EPIGRALSpecialty Chemicals
Epigral Ltd — Cash Flow Statement
₹839.00
-5.15%
Epigral Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 245.87 Cr | -0.80 Cr | 209.71 Cr | -172.48 Cr | — |
| Repurchase Of Capital Stock | -95.00 Cr | -55.00 Cr | -60.92 Cr | 0.00 | — |
| Repayment Of Debt | -248.55 Cr | -196.26 Cr | -139.10 Cr | -120.05 Cr | — |
| Issuance Of Debt | 137.00 Cr | 213.00 Cr | 74.75 Cr | 359.30 Cr | — |
| Issuance Of Capital Stock | 333.05 Cr | 0.00 | — | — | — |
| Capital Expenditure | -194.69 Cr | -398.44 Cr | -416.45 Cr | -456.30 Cr | — |
| End Cash Position | 18.64 Cr | 3.18 Cr | 14.24 Cr | 25.09 Cr | — |
| Beginning Cash Position | 3.18 Cr | 14.24 Cr | 25.09 Cr | 0.68 Cr | — |
| Changes In Cash | 15.46 Cr | -11.06 Cr | -10.85 Cr | 24.41 Cr | — |
| Financing Cash Flow | -163.54 Cr | -7.60 Cr | -199.79 Cr | 195.22 Cr | — |
| Interest Paid Cff | -65.94 Cr | -72.02 Cr | -60.45 Cr | -48.04 Cr | — |
| Cash Dividends Paid | -41.86 Cr | -25.12 Cr | -24.22 Cr | — | — |
| Preferred Stock Dividend Paid | -10.32 Cr | -14.75 Cr | -13.85 Cr | 0.00 | — |
| Common Stock Dividend Paid | -31.54 Cr | -10.37 Cr | -10.37 Cr | 0.00 | — |
| Net Preferred Stock Issuance | -95.00 Cr | -55.00 Cr | -60.92 Cr | 0.00 | — |
| Preferred Stock Payments | -95.00 Cr | -55.00 Cr | -60.92 Cr | 0.00 | — |
| Net Common Stock Issuance | 333.05 Cr | 0.00 | — | — | — |
| Common Stock Issuance | 333.05 Cr | 0.00 | — | — | — |
| Net Issuance Payments Of Debt | -283.10 Cr | 145.98 Cr | -52.78 Cr | 244.36 Cr | — |
| Net Short Term Debt Issuance | -171.55 Cr | 129.24 Cr | 11.57 Cr | 5.11 Cr | — |
| Short Term Debt Payments | -171.55 Cr | — | — | — | — |
| Net Long Term Debt Issuance | -111.55 Cr | 16.74 Cr | -64.35 Cr | 239.25 Cr | — |
| Long Term Debt Payments | -248.55 Cr | -196.26 Cr | -139.10 Cr | -120.05 Cr | — |
| Long Term Debt Issuance | 137.00 Cr | 213.00 Cr | 74.75 Cr | 359.30 Cr | — |
| Investing Cash Flow | -261.56 Cr | -401.10 Cr | -437.22 Cr | -454.63 Cr | — |
| Net Other Investing Changes | 0.42 Cr | -2.74 Cr | -0.87 Cr | — | — |
| Interest Received Cfi | 0.26 Cr | 0.08 Cr | 0.67 Cr | 0.29 Cr | — |
| Net Investment Purchase And Sale | -75.47 Cr | -2.74 Cr | -0.02 Cr | 1.38 Cr | — |
| Sale Of Investment | 233.57 Cr | 0.00 | — | 1.38 Cr | — |
| Purchase Of Investment | -309.04 Cr | -2.74 Cr | -0.02 Cr | 0.00 | — |
| Net PPE Purchase And Sale | -186.35 Cr | -398.44 Cr | -416.45 Cr | -456.30 Cr | — |
| Sale Of PPE | 8.34 Cr | 0.00 | — | 0.00 | 0.05 Cr |
| Purchase Of PPE | -194.69 Cr | -398.44 Cr | -416.45 Cr | -456.30 Cr | — |
| Operating Cash Flow | 440.56 Cr | 397.64 Cr | 626.16 Cr | 283.82 Cr | — |
| Taxes Refund Paid | -110.45 Cr | -50.53 Cr | -107.48 Cr | -60.45 Cr | — |
| Change In Working Capital | -166.68 Cr | -38.40 Cr | 40.82 Cr | -169.41 Cr | — |
| Change In Other Current Liabilities | 11.65 Cr | -0.29 Cr | -2.03 Cr | 56.08 Cr | — |
| Change In Other Current Assets | -2.99 Cr | -31.28 Cr | -12.58 Cr | -3.78 Cr | — |
| Change In Payable | 3.08 Cr | 55.33 Cr | 22.41 Cr | 14.77 Cr | — |
| Change In Inventory | -125.00 Cr | -51.16 Cr | -57.69 Cr | -100.18 Cr | — |
| Change In Receivables | -53.80 Cr | -12.47 Cr | 90.50 Cr | -137.60 Cr | — |
| Other Non Cash Items | 46.62 Cr | 73.40 Cr | 64.66 Cr | 44.11 Cr | — |
| Depreciation And Amortization | 132.56 Cr | 123.56 Cr | 108.95 Cr | 85.91 Cr | — |
| Amortization Cash Flow | 3.23 Cr | 3.23 Cr | 3.23 Cr | — | — |
| Depreciation | 129.33 Cr | 120.33 Cr | 108.95 Cr | 85.91 Cr | — |
| Gain Loss On Investment Securities | 4.02 Cr | 3.33 Cr | -1.31 Cr | — | -5.29 Cr |
| Net Foreign Currency Exchange Gain Loss | -0.59 Cr | -4.49 Cr | -0.75 Cr | 0.29 Cr | — |
| Gain Loss On Sale Of PPE | -5.04 Cr | 0.05 Cr | 49000.00 | 0.07 Cr | — |
| Net Income From Continuing Operations | 540.10 Cr | 290.72 Cr | 522.48 Cr | 383.42 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | 1000.00 | — | 1000.00 |
| Net Other Financing Charges | — | 1000.00 | -1000.00 | — | — |
| Short Term Debt Issuance | — | 129.24 Cr | 11.57 Cr | 5.11 Cr | 55.31 Cr |
| Net Business Purchase And Sale | — | 0.00 | -20.54 Cr | 0.00 | 0.00 |
| Purchase Of Business | — | 0.00 | -20.54 Cr | 0.00 | 0.00 |
| Provisionand Write Offof Assets | — | — | 0.00 | -0.12 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Epigral Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.